Cite
HARVARD Citation
Zanetti, S. et al. (2020). Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity. Journal for immunotherapy of cancer. 8 (2), p. . [Online].